These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30128768)
1. Evaluation of immunohistochemical expression of survivin and its correlation with -31G/C gene polymorphism in colorectal cancer. Heidari Z; Sagheb HM; Hakimi A; Moudi B Med Mol Morphol; 2019 Jun; 52(2):82-89. PubMed ID: 30128768 [TBL] [Abstract][Full Text] [Related]
2. The association between survivin -31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population. Huang J; Wei Y; Zhou X; Wang L; Huang M; Wang J J Cancer Res Ther; 2019; 15(1):82-86. PubMed ID: 30880759 [TBL] [Abstract][Full Text] [Related]
3. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population. Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population. Li XB; Li SN; Yang ZH; Cao L; Duan FL; Sun XW DNA Cell Biol; 2013 May; 32(5):236-42. PubMed ID: 23581553 [TBL] [Abstract][Full Text] [Related]
5. Association of the DNMT3B polymorphism with colorectal adenomatous polyps and adenocarcinoma. Guo X; Zhang L; Wu M; Wang N; Liu Y; Er L; Wang S; Gao Y; Yu W; Xue H; Xu Z; Wang S Mol Biol Rep; 2010 Jan; 37(1):219-25. PubMed ID: 19626461 [TBL] [Abstract][Full Text] [Related]
6. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675 [TBL] [Abstract][Full Text] [Related]
7. Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer. Asadian F; Ghadyani M; Antikchi MH; Dastgheib SA; Neamatzadeh H; Sheikhpour E; Khajehnoori S; Tabei SS J Gastrointest Cancer; 2022 Mar; 53(1):78-83. PubMed ID: 33180239 [TBL] [Abstract][Full Text] [Related]
8. Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt. Motawi TMK; Zakhary NI; Darwish HA; Abdalla HM; Tadros SA Clin Breast Cancer; 2019 Apr; 19(2):e276-e282. PubMed ID: 30765238 [TBL] [Abstract][Full Text] [Related]
9. The -31 G/C promoter gene polymorphism of surviving in Turkish colorectal cancers patients. Budak M; Bozkurt C; Cetin SE; Tuncel H Ceylon Med J; 2018 Sep; 63(3):119-123. PubMed ID: 30415515 [TBL] [Abstract][Full Text] [Related]
10. Correlation between survivin genetic polymorphisms and lung cancer susceptibility. Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647 [TBL] [Abstract][Full Text] [Related]
11. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk. Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739 [TBL] [Abstract][Full Text] [Related]
12. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development. Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797 [TBL] [Abstract][Full Text] [Related]
13. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility. Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810 [TBL] [Abstract][Full Text] [Related]
14. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population. Bayram S; Akkız H; Bekar A; Akgöllü E Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634 [TBL] [Abstract][Full Text] [Related]
15. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development. Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915 [TBL] [Abstract][Full Text] [Related]
16. The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival. Antonacopoulou AG; Floratou K; Bravou V; Kottorou A; Dimitrakopoulos FI; Marousi S; Stavropoulos M; Koutras AK; Scopa CD; Kalofonos HP Anal Cell Pathol (Amst); 2010; 33(5):177-89. PubMed ID: 20978324 [TBL] [Abstract][Full Text] [Related]
17. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer. Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871 [TBL] [Abstract][Full Text] [Related]
18. PTEN expression profiles in colorectal adenocarcinoma and its precancerous lesions. Waniczek D; Śnietura M; Młynarczyk-Liszka J; Pigłowski W; Kopeć A; Lange D; Rudzki M; Arendt J Pol J Pathol; 2013 Apr; 64(1):15-20. PubMed ID: 23625595 [TBL] [Abstract][Full Text] [Related]
19. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population. Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057 [TBL] [Abstract][Full Text] [Related]
20. Impact of EXO1 polymorphism in susceptibility to colorectal cancer. Haghighi MM; Taleghani MY; Mohebbi SR; Vahedi M; Fatemi SR; Zali N; Shemirani AI; Zali MR Genet Test Mol Biomarkers; 2010 Oct; 14(5):649-52. PubMed ID: 20854105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]